Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

November 01, 2018; Volume 15,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Bai, Changsen

    1. You have access
      PKM2 promotes reductive glutamine metabolism
      Miao Liu, Yuanyuan Wang, Yuxia Ruan, Changsen Bai, Li Qiu, Yanfen Cui, Guoguang Ying and Binghui Li
      Cancer Biology & Medicine November 2018, 15 (4) 389-399; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0122
  2. Bai, Yuchen

    1. You have access
      PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs
      Yuchen Bai, Xiaoxia Chen, Likun Hou, Jun Qian, Tao Jiang, Caicun Zhou and Maciej Ciebiada
      Cancer Biology & Medicine November 2018, 15 (4) 434-442; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0223
  3. Bonello, Maria

    1. You have access
      Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer
      Maria Bonello, Andrew Harvey Sims and Simon Peter Langdon
      Cancer Biology & Medicine November 2018, 15 (4) 375-388; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0062
  4. Brassesco, María Sol

    1. You have access
      G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future
      Angel Mauricio Castro-Gamero, Julia Alejandra Pezuk, María Sol Brassesco and Luiz Gonzaga Tone
      Cancer Biology & Medicine November 2018, 15 (4) 354-374; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0030
  5. Cao, Dengfeng

    1. You have access
      Multidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumor
      Qiujuan Huang, Changxu Liu, Ruijun Tang, Jie Li, Wei Li, Lei Zhu, Yuhong Guo, Lin Zhang, Tongyuan Qu, Lingyi Yang, Lingmei Li, Yalei Wang, Baocun Sun, Bin Meng, Jie Yan, Wengui Xu, Huilai Zhang, Dengfeng Cao and Wenfeng Cao
      Cancer Biology & Medicine November 2018, 15 (4) 461-467; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0054
  6. Cao, Wenfeng

    1. You have access
      Multidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumor
      Qiujuan Huang, Changxu Liu, Ruijun Tang, Jie Li, Wei Li, Lei Zhu, Yuhong Guo, Lin Zhang, Tongyuan Qu, Lingyi Yang, Lingmei Li, Yalei Wang, Baocun Sun, Bin Meng, Jie Yan, Wengui Xu, Huilai Zhang, Dengfeng Cao and Wenfeng Cao
      Cancer Biology & Medicine November 2018, 15 (4) 461-467; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0054
  7. Castro-gamero, Angel Mauricio

    1. You have access
      G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future
      Angel Mauricio Castro-Gamero, Julia Alejandra Pezuk, María Sol Brassesco and Luiz Gonzaga Tone
      Cancer Biology & Medicine November 2018, 15 (4) 354-374; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0030
  8. Chen, Li

    1. You have access
      Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study
      Long Yuan, Xiaowei Qi, Yi Zhang, Xinhua Yang, Fan Zhang, Linjun Fan, Li Chen, Kongyong Zhang, Ling Zhong, Yanling Li, Sijie Gan, Wenying Fu and Jun Jiang
      Cancer Biology & Medicine November 2018, 15 (4) 452-460; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0270
  9. Chen, Lin

    1. You have access
      A new tumor-associated antigen prognostic scoring system for spontaneous ruptured hepatocellular carcinoma after partial hepatectomy
      Jingjing Wu, Peng Zhu, Zhanguo Zhang, Bixiang Zhang, Chang Shu, Lin Chen, Renjie Feng, Abdoul aziz Mba'nbo koumpa, Ganxun Li and Qianyun Ge
      Cancer Biology & Medicine November 2018, 15 (4) 415-424; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0095
  10. Chen, Weiqiang

    1. You have access
      Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment
      Jing Wang, Yizhuo Zhao, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Hao Yu, Yang Zhao, Weiqiang Chen, Yi Luo, Xiuwen Wang, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li, Zhujun Liu, Baohui Han and Kai Li
      Cancer Biology & Medicine November 2018, 15 (4) 443-451; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0158
« Previous (Pages : 1 2 3 4 5 6 ... 14) Next »
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 15 (4)
Cancer Biology & Medicine
Vol. 15, Issue 4
1 Nov 2018
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire